Ba
Non vérifié

Bavarian Nordic A/S

Ce que nous écrivons

BiotechnologieFinanceManagement/Organisation d'EntreprisePolitique ÉtrangèrePublicité/Marketing/Médias/Communication
11/03/2026
Biotechnologie
Finance
Politique Étrangère
Bavarian Nordic Publishes Annual Report 2025
1.00
11/03/2026
Biotechnologie
Management/Organisation d'Entreprise
Médecine Santé Bien-être
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
1.00
01/03/2026
Biotechnologie
Politique Étrangère
Paul Chaplin Steps Down as CEO of Bavarian Nordic
1.00
17/02/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada
1.00
22/01/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
1.00
16/12/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
1.00
01/12/2025
Biotechnologie
Politique Étrangère
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
1.00
26/11/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
1.00
13/11/2025
Biotechnologie
Management/Organisation d'Entreprise
Politique Étrangère
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0